Inspire Medical Systems, Inc., a medical technology company, focuses on the development and commercialization of minimally invasive solutions for patients with obstructive sleep apnea (OSA). It offers Inspire system, a neurostimulation technology that provides a safe and effective treatment for moderate to severe obstructive sleep apnea. The company was founded in 2007 and is headquartered in Maple Grove, Minnesota.
Industry, Sector and Symbol
Stock Exchange NASDAQ
Industry Medical Devices
Sub-IndustryN/A
SectorMedical
Current SymbolNASDAQ:INSP
Previous Symbol
CUSIPN/A
PhoneN/A
Debt
Debt-to-Equity RatioN/A
Current RatioN/A
Quick RatioN/A
Price-To-Earnings
Trailing P/E RatioN/A
Forward P/E RatioN/A
P/E GrowthN/A
Sales & Book Value
Annual SalesN/A
Price / SalesN/A
Cash FlowN/A
Price / Cash FlowN/A
Book ValueN/A
Price / BookN/A
Profitability
EPS (Most Recent Fiscal Year)N/A
Net IncomeN/A
Net MarginsN/A
Return on EquityN/A
Return on AssetsN/A
Miscellaneous
EmployeesN/A
Outstanding Shares21,400,000
Market Cap$0.00
OptionableOptionable
Inspire Medical Systems (NASDAQ:INSP) Frequently Asked Questions
What is Inspire Medical Systems' stock symbol?
Inspire Medical Systems trades on the NASDAQ under the ticker symbol "INSP."
How were Inspire Medical Systems' earnings last quarter?
Inspire Medical Systems (NASDAQ:INSP) issued its quarterly earnings data on Tuesday, November, 6th. The company reported ($0.22) earnings per share (EPS) for the quarter, beating the consensus estimate of ($0.35) by $0.13. The company earned $13.10 million during the quarter, compared to analysts' expectations of $12.86 million. The firm's quarterly revenue was up 79.9% on a year-over-year basis. During the same quarter last year, the firm posted ($3.42) earnings per share. View Inspire Medical Systems' Earnings History.
When is Inspire Medical Systems' next earnings date?
What guidance has Inspire Medical Systems issued on next quarter's earnings?
Inspire Medical Systems issued an update on its FY 2018 earnings guidance on Tuesday, November, 6th. The company provided EPS guidance of for the period. The company issued revenue guidance of $47.5-48 million, compared to the consensus revenue estimate of $44.17 million.
What price target have analysts set for INSP?
7 brokers have issued twelve-month price targets for Inspire Medical Systems' stock. Their forecasts range from $25.00 to $57.00. On average, they expect Inspire Medical Systems' share price to reach $38.4286 in the next year. This suggests that the stock has a possible downside of 7.5%. View Analyst Price Targets for Inspire Medical Systems.
What is the consensus analysts' recommendation for Inspire Medical Systems?
7 Wall Street analysts have issued "buy," "hold," and "sell" ratings for Inspire Medical Systems in the last year. There are currently 1 sell rating, 2 hold ratings and 4 buy ratings for the stock, resulting in a consensus recommendation of "Hold." View Analyst Ratings for Inspire Medical Systems.
Has Inspire Medical Systems been receiving favorable news coverage?
News coverage about INSP stock has trended positive recently, InfoTrie Sentiment Analysis reports. The research firm identifies positive and negative media coverage by monitoring more than six thousand blog and news sources. The firm ranks coverage of public companies on a scale of negative five to positive five, with scores nearest to five being the most favorable. Inspire Medical Systems earned a coverage optimism score of 2.6 on InfoTrie's scale. They also assigned news articles about the company a news buzz of 2.0 out of 10, meaning that recent media coverage is very unlikely to have an impact on the stock's share price in the near term.
Who are some of Inspire Medical Systems' key competitors?
Some companies that are related to Inspire Medical Systems include Activecare (ACAR), Advanced Oncotherapy (AVO), Airware Labs (AIRW), Anteo Diagnostics (ADO), Aurora Spine (ASG), Avacta Group (AVCT), Azure Healthcare (AZV), Biosig Technologies (BSGM), Cannabix Technologies (BLOZF), Cochlear (COH), ConvaTec Group (CTEC), Creo Medical Group (CREO), Draegerwerk AG & Co KGaA (DRW3), Electromed (ELMD) and Ellex Medical Lasers (ELXMF).
Who are Inspire Medical Systems' key executives?
Inspire Medical Systems' management team includes the folowing people:
- Mr. Tim Herbert, Chief Exec. Officer and Pres
- Mr. Richard Buchholz, Chief Financial Officer
- Mr. Randy Ban, Sr. VP of Sales and Marketing
- Mr. Sean Cleary, VP of Global Market Devel.
- Mr. Gary A. Goetzke, VP of Health Economics
When did Inspire Medical Systems IPO?
(INSP) raised $75 million in an initial public offering (IPO) on Thursday, May 3rd 2018. The company issued 5,000,000 shares at $14.00-$16.00 per share. BofA Merrill Lynch and Goldman Sachs served as the underwriters for the IPO and Guggenheim Securities, Stifel and Wells Fargo Securities were co-managers.
When did Inspire Medical Systems' lock-up period expire?
Inspire Medical Systems' lock-up period expired on Tuesday, October 30th. Inspire Medical Systems had issued 6,750,000 shares in its IPO on May 3rd. The total size of the offering was $108,000,000 based on an initial share price of $16.00. Since the end of Inspire Medical Systems' lock-up period, restrictions preventing company insiders and major shareholders from selling shares in the company have been lifted.
Who are Inspire Medical Systems' major shareholders?
Inspire Medical Systems' stock is owned by many different of retail and institutional investors. Top institutional investors include Franklin Resources Inc. (2.88%), BlackRock Inc. (2.56%), Vanguard Group Inc. (1.63%), Vanguard Group Inc (1.63%), Citadel Advisors LLC (0.89%) and Gilder Gagnon Howe & Co. LLC (0.71%). Company insiders that own Inspire Medical Systems stock include Amzak Health Investors, Llc, Jerry C Griffin, Marilyn C Nelson, Randy Ban, Richard Buchholz, Steven Jandrich and Timothy P Herbert. View Institutional Ownership Trends for Inspire Medical Systems.
Which major investors are selling Inspire Medical Systems stock?
INSP stock was sold by a variety of institutional investors in the last quarter, including Hodges Capital Management Inc., Wells Fargo & Company MN, EAM Investors LLC, BlackRock Inc., Pentwater Capital Management LP, TIAA CREF Investment Management LLC and JPMorgan Chase & Co.. Company insiders that have sold Inspire Medical Systems company stock in the last year include Jerry C Griffin, Randy Ban and Timothy P Herbert. View Insider Buying and Selling for Inspire Medical Systems.
Which major investors are buying Inspire Medical Systems stock?
INSP stock was bought by a variety of institutional investors in the last quarter, including Citadel Advisors LLC, Osterweis Capital Management Inc., American Century Companies Inc., Columbus Circle Investors, Bellevue Group AG, Franklin Resources Inc., Macquarie Group Ltd. and Credit Suisse AG. Company insiders that have bought Inspire Medical Systems stock in the last two years include Amzak Health Investors, Llc, Marilyn C Nelson, Randy Ban, Richard Buchholz, Steven Jandrich and Timothy P Herbert. View Insider Buying and Selling for Inspire Medical Systems.
How do I buy shares of Inspire Medical Systems?
Shares of INSP can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Scottrade, Fidelity and Charles Schwab.
What is Inspire Medical Systems' stock price today?
One share of INSP stock can currently be purchased for approximately $41.56.
What is Inspire Medical Systems' official website?
MarketBeat Community Rating for Inspire Medical Systems (NASDAQ INSP)
MarketBeat's community ratings are surveys of what our community members think about Inspire Medical Systems and other stocks. Vote "Outperform" if you believe INSP will outperform the S&P 500 over the long term. Vote "Underperform" if you believe INSP will underperform the S&P 500 over the long term. You may vote once every thirty days.
